Evidence map›Paper›PMID 40027615›Full record

ArticlebioRxiv : the preprint server for biology2025

BRCA1-A and LIG4 complexes mediate ecDNA biogenesis and cancer drug resistance.

Oliver W Chung, Shun Yao, Fu Yang, Ling Wang, Christian Cerda-Smith, Haley M Hutchinson, Kris C Wood, Weijia Su, Mustafa Khasraw, Lee Zou and 2 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Oliver W ChungDepartment of Pharmacology & Cancer Biology, Duke University School of Medicine, Durham, USA.
Shun YaoDepartment of Pharmacology & Cancer Biology, Duke University School of Medicine, Durham, USA.
Fu YangDepartment of Pharmacology & Cancer Biology, Duke University School of Medicine, Durham, USA.
Ling WangDepartment of Pharmacology & Cancer Biology, Duke University School of Medicine, Durham, USA.
Christian Cerda-SmithDepartment of Pharmacology & Cancer Biology, Duke University School of Medicine, Durham, USA.
Haley M HutchinsonDepartment of Pharmacology & Cancer Biology, Duke University School of Medicine, Durham, USA.
Kris C WoodDepartment of Pharmacology & Cancer Biology, Duke University School of Medicine, Durham, USA.
Weijia SuDepartment of Pharmacology & Cancer Biology, Duke University School of Medicine, Durham, USA.
Mustafa KhasrawThe Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University Medical Center, Durham, USA.
Lee ZouDepartment of Pharmacology & Cancer Biology, Duke University School of Medicine, Durham, USA.
Dale A RamsdenLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, USA.
Zz Zhao ZhangDepartment of Pharmacology & Cancer Biology, Duke University School of Medicine, Durham, USA.

Funding

Structural determinants of Pol theta functionP01CA247773 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Sylvie Doublie · 2020 to 2026
$15.2M
The Role of DNA Synthesis in Nonhomologous End JoiningR01CA097096 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DALE A RAMSDEN · 2003 to 2026
$5.5M
Resolution of Complex Breaks by Nonhomologous End JoiningR01CA084442 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RAMSDEN, DALE A · 2000 to 2019
$4.8M
Mechanism-based targeting of unique survival signaling in residual tumorsR01CA263593 · NCI · DUKE UNIVERSITY · PI Kris C. Wood · 2022 to 2026
$1.7M
Regulation, function, and impact of developmental retrotransposon activationR01GM141018 · NIGMS · DUKE UNIVERSITY · PI ZHANG, ZHAO · 2021 to 2024
$1.3M
Biogenesis and function of retrotransposon-derived circular DNAR01GM152423 · NIGMS · DUKE UNIVERSITY · PI ZHANG, ZHAO · 2024 to 2025
$864k
Sex differences in DNA damage responseR21CA263394 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SCHMITZ, JOHN C · 2022 to 2023
$404k
Identification and Characterization of Novel Cis-Regulatory Elements Controlling PTEN ExpressionF30CA247323 · NCI · DUKE UNIVERSITY · PI CERDA-SMITH, CHRISTIAN GONZALO · 2020 to 2022
$129k
NCI NIH HHS F30 CA247323NCI NIH HHS P01 CA247773NCI NIH HHS R01 CA084442NCI NIH HHS R01 CA097096NCI NIH HHS R01 CA263593NCI NIH HHS R21 CA263394NIGMS NIH HHS R01 GM141018NIGMS NIH HHS R01 GM152423
6 · The paper itself

Abstract

Extrachromosomal circular DNA (ecDNA) are commonly produced within the nucleus to drive genome dynamics and heterogeneity, enabling cancer cell evolution and adaptation. However, the mechanisms underlying ecDNA biogenesis remain poorly understood. Here using genome-wide CRISPR screening in human cells, we identified the BRCA1-A and the LIG4 complexes mediate ecDNA production. Following DNA fragmentation, the upstream BRCA1-A complex protects DNA ends from excessive resection, promoting end-joining for circularization. Conversely, the MRN complex, which mediates end resection and thus antagonizes the BRCA1-A complex, suppresses ecDNA formation. Downstream, LIG4 conservatively catalyzes ecDNA production in

Identifiers

PMID40027615
PMCPMC11870461

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.